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1 Ganglioside and glycosphingolipid nomenclature is
holm [1].The plasma membrane (PM) sphingolipid composition is the result of a series of well-known met-
abolic pathways comprising neobiosynthesis in the endoplasmic reticulum and in the Golgi appara-
tus followed by vesicular delivery to the plasma membrane, membrane turnover with ﬁnal
catabolism in lysosomes, and shedding of membrane components. In addition to this, the head
group of PM sphingolipids can be opportunely modiﬁed by the action of PM associated hydrolases
and transferases. The number of enzymes for glycosphingolipid metabolism that have been shown
to be associated with the plasma membrane and the information on their properties are growing
very rapidly. In this review, we will focus on the possible role and on the involvement of the plasma
membrane-associated glycohydrolases in modulating cell functions.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Biological functions of plasma membrane glycosphingolipids
Sphingolipids are amphiphilic components characterized by the
presence of ceramide inserted into the lipid membrane layer and a
hydrophilic head group protruding in the aqueous extracellular
medium. Within sphingolipids, glycosphingolipids1 are ubiquitous
components of mammalian cell membranes. In the plasma mem-
brane they reside asymmetrically in the extracellular leaﬂet, where
they represent relatively abundant components, particularly in the
nervous system. Keeping in mind that sphingolipids are not homoge-
neously distributed throughout the membrane surface, but rather
they are further concentrated in restricted membrane areas due tochemical Societies. Published by E
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in accordance with Svenner-their spontaneous segregation respect to glycerophospholipids [2],
it can be predicted that their local concentration in speciﬁc lipid
membrane domains, known as ‘‘lipid rafts” should be very high. It
is believed that in the lipid rafts, glycosphingolipids modulate the
functional features of several membrane proteins through direct
speciﬁc lipid-to-protein interactions or through the maintenance of
a dynamic membrane organization [3].
Glycosphingolipids (GSL) are essential for life. Glycolipid-deﬁ-
cient cells can survive, grow and respond to functional stimuli
when cultured in vitro [4]. On the other hand, ceramide glucosyl-
transferase knockout mice are embryonic lethal, showing no cellu-
lar differentiation beyond the primitive germ layers [5] and neural
cell-speciﬁc deletion of this enzyme in mice leads to severe neuro-
logical defects in the early postnatal life and death within 3 weeks
[6], demonstrating the importance of GSL for the survival, prolifer-
ation and differentiation of eukaryotic cells within complex multi-
cellular systems, and in particular for the maturation of the
nervous system. Not surprisingly, given their peculiar structure
and topology, GSL affect several biological events that are crucial
for the interaction of cells with the extracellular environment,
engaging both trans and cis functional interactions with other cel-
lular components. Lipid-bound oligosaccharides at the cell surface
act as receptors or co-receptors, being recognized by soluble
ligands as, for example the cholera toxin for GM1 [7], and thelsevier B.V. All rights reserved.
S. Sonnino et al. / FEBS Letters 584 (2010) 1914–1922 1915verotoxin for Gb3 [8], or by complementary carbohydrates (e.g.,
GM3–Gg3 interactions mediating the adhesion of melanoma cells
[9]) and by carbohydrate-binding proteins (e.g., GD1a and GT1b
gangliosides by myelin-associated glycoprotein [10]) belonging to
the interfacing membrane of adjacent cells. On the other hand,
GSL are able to laterally interact with and to modulate the function
of several membrane proteins [11–15]) by cis interactions. cis
interactions involving GSL encompass both structure-speciﬁc di-
rect lateral interactions with plasma membrane proteins and short
range alterations of the physico-chemical properties of the protein
membrane microenvironment. Since GSL are highly segregated to-
gether with cholesterol in liquid-ordered lipid domains with
locally reduced ﬂuidity [2], it can be hypothesized that proteins
co-segregated with GSL have a restricted lateral motility, favoring
more stable interactions with other proteins segregated in the
same domains or with GSL. Alternatively, the association of a pro-
tein with a rigid GSL-enriched membrane area could induce con-
formational changes in protein inﬂuencing its biological function,
even in the absence of high afﬁnity lateral interactions with GSL.
The oligosaccharide chains of GSL provide a wide variety of poten-
tial sites for speciﬁc lipid–proteins lateral interactions. Several
examples of GSL–protein interactions leading to the modulation
of the activity of membrane-associated proteins have been
described.
In the case of receptor-associated tyrosine kinases, well-studied
examples are represented by the interaction of GM3 with epider-
mal growth factor receptor (EGFR) [16], and with insulin receptor
(IR) [17,18] and of GM1 with Trk neurotrophin receptor and with
platelet-derived growth factor receptor (PDGFR).
EGFR is inhibited in its function by GM3 [19], explaining the
inhibitory effect of this ganglioside on cell growth. GM3 inhibits
EGFR autophosphorylation without affecting the binding of EGF
with the receptor [19]. GM3 effect is speciﬁc [19] and implies a di-
rect side-by-side carbohydrate–carbohydrate interaction between
the sialyllactose oligosaccharide of GM3 [19] and a N-linked glycan
on the receptor [20]. GM3/EGFR interaction is facilitated by co-seg-
regation within lipid rafts, and is probably modulated by other li-
pid raft components, including caveolin-1 [21,22] and integrin b1
subunit [23].
IR can form a membrane complex with GM3 within lipid mem-
brane domains [24], likely involving a direct interaction between
the negatively charged sialyllactose chain of GM3 and the
positively charged amino group of lysine 944, located in close
proximity to the transmembrane domain sequence of IR. In insu-
lin-resistant adipocytes, GM3 synthase was upregulated and GM3
was consistently accumulated [17] in detergent-resistant mem-
branes leading to the displacement of IR from a complex with cave-
olin-1 and reduced response to insulin in terms of GLUT4 mediated
glucose uptake [24].
GM1 can speciﬁcally and tightly bind Trk [25], leading to Trk ki-
nase activation, receptor autophosphorylation and dimerization
[26–28] thus explaining the positive effect of this ganglioside on
neuronal growth, differentiation and survival [26]. The extracellu-
lar portion and the glycosylation of Trk receptor are essential for
the formation of Trk–GM1 complexes [29] and for GM1-induced
receptor activation [27] suggesting that lateral interactions be-
tween the oligosaccharide chains of the receptor and those of
GM1 are responsible for receptor ﬁne tuning.
GM1 can negatively affect PDGFR phosphorylation and dimer-
ization, thus inhibiting PDGF-dependent cell growth [30]. In-
creased GM1 plasma membrane levels due to the ectopic
expression of the N-terminal domain of Csk-binding protein PAG,
or exogenous GM1 administration lead to the displacement of
PDGFR from caveolae, negatively regulating downstream Src-med-
iated mitogenic signaling [31]. However, in this case it is not
known whether the formation of a PDGFR–GM1 complex is re-quired for its uncoupling from caveolae. The localization of PDGFR
in caveolae requires the formation of a complex with caveolin-1,
and since caveolin-1 can directly bind sphingolipids, a displace-
ment of the receptor could be due to the competition between
GM1 and PDGFR for the formation of a complex with caveolin-1.
Another class of membrane proteins that have been shown to
be modulated by GSL are the non-receptor tyrosine kinases of
the Src family (c-Src and Lyn), acylated proteins associated with
the cytosolic side of the plasma membrane that are highly associ-
ated with GSL-rich membrane domains in all cell types so far
investigated. In this case, the interactions between GSL and pro-
teins are particularly enigmatic due to the location of the interac-
tors on the opposite sides of the plasma membrane, and are likely
very complex.
In Neuro2a neuroblastoma cells, GM1 and GM3 are able to in-
duce neuritogenesis in a Trk-independent fashion, apparently via
the activation of c-Src [32]. In this case, the neuritogenic effect of
gangliosides was observed after very short treatment and under
experimental conditions that likely do not allow the stable inser-
tion of the exogenously administered ganglioside in the plasma
membrane, suggesting that GM1 can activate the receptor without
the need of lateral interactions between ganglioside and receptor
[28,32].
In cerebellar neurons and rat brain, GD3 ganglioside is closely
associated with the GPI-anchored neuronal cell adhesion molecule
TAG-1 and with Lyn [13]. Antibody-induced cross-linking of TAG-1
induced Lyn activation and phosphorylation of downstream Lyn
substrates, an event that was abolished by the cell surface hydro-
lysis of GSL by endoglycoceramidase treatment or by the pharma-
cological inhibition of sphingolipid biosynthesis [33].
The formation of integrin a3 or a5 receptor subunits/tetra-
spanin CD9/GM3 complexes (‘‘type 3 glycosynapse”) is responsible
for the recruitment of the c-Src kinase Csk, the physiological inhib-
itor of Src, to the plasma membrane, with consequent phosphory-
lation of c-Src at Tyr527 and c-Src inactivation, leading to reduced
adhesion and motility [34] in tumor cell lines. A still unidentiﬁed
speciﬁc GSL-protein interaction involving the sialyllactose oligo-
saccharide chain of GM3 is likely involved in glycosynapse-medi-
ated Src inhibition signaling, since GM3 only, but not other GSL
(including GM1, GD1a or lactosylceramide (LacCer) [34]), is effec-
tive in this regard.
LacCer, the most abundant GSL in human neutrophils, acts as a
surface receptor for several pathogenic microorganisms and neu-
trophil treatment with anti-LacCer antibodies induces the phos-
phorylation of Lyn with consequent chemotaxis, phagocytosis
and superoxide generation [35]. LacCer in human neutrophils co-
localizes with Lyn at the cell surface and can be co-immunoprecip-
itated with this protein [36,37], suggesting that anti-LacCer
mediated Lyn activation might require the formation of a mem-
brane complex between Lyn and LacCer. Interestingly, the physical
and functional association of Lyn with LacCer requires both the lac-
tose sugar chain and the presence in the hydrophobic portion of
the lipid of a very long chain fatty acid (C24:0 or C24:1), suggesting
a role for cross-bilayer van der Waals interactions between the GSL
acyl chains and those of Lyn [35–37].2. Metabolism of plasma membrane glycosphingolipids
Plasma membranes contain the larger part of cell glyco-
sphingolipids inserted into the membrane outer layer. The regula-
tion of plasma membrane sphingolipid content and pattern
involves neobiosynthesis, catabolism and a complex intracellular
trafﬁcking and exchanges with the extracellular environment.
Any change of these pathways can contribute in modifying
the plasma membrane glycosphingolipid composition and
1916 S. Sonnino et al. / FEBS Letters 584 (2010) 1914–1922organization and could be of great importance for the cell biology.
A general scheme on the glycosphingolipid metabolism is depicted
in Fig. 1.
De novo biosynthesis requires the availability of ceramide, the
biosynthesis of which occurs in the endoplasmic reticulum. Cera-
mide is transported as complexes with proteins (CERT) and vesicles
to the Golgi apparatus [38], where the synthesis is completed. Cer-
amide is ﬁrstly glycosylated to glucosylceramide (GlcCer) on the
cytosolic leaﬂet of cis-Golgi membranes by GlcCer synthase. From
this site, the GlcCer reaches, by vesicular transport, by ﬂip ﬂop
and/or by a transport FAPP2-mediated, the lumen of the late-Golgi
compartments where the synthesis of more complex GSL takes
place [39–42]. Neobiosynthesized sphingolipids move via vesicular
transport to the plasma membranes, becoming components of the
external leaﬂet. Catabolism of sphingolipids occurs in lysosomes,
from which less complex products, obtained in the degradation
pathway, can escape. Nevertheless, only a minor portion of the
endocytic vesicles becomes lysosomes, while the larger part rap-
idly re-associates with the plasma membrane [43–45]. Some
sphingolipids are released from the plasma membranes into the
extracellular environment [46] and, on the other hand, sphingoli-
pids present in the extracellular milieu are at least in part taken
up by cells, becoming components of the membranes and contrib-
uting to modify their composition, or are sorted directly to the
lysosomes [47]. Both sphingolipid catabolic (hydrolases) and bio-
synthetic (transferases) enzymes have been found associated with
the plasma membranes, where it has been proven that they display
activity on the membrane components [48–52].ceramide
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Fig. 1. Different metabolic pathways determining plasma membrane glycosphingolipid
indicate oligosaccharide transformations occurring at the cell surface. Azure arrows i
occurring in the membrane. Dotted arrows indicate a transport determined indirectly, bu
several subcellular particles.The notions on the glycosphingolipid intracellular metabolic
pathways are under continuous investigations. Moreover, the real
rate and the entity of this process in living organisms are not yet
so well known and very little is known about the regulation of gly-
colipid biosynthesis. It is generally assumed that glycolipid biosyn-
thesis is mainly regulated at the transcriptional level through the
control of the expression levels of glycosyltransferases or trans-
porter proteins. Indeed, changes in cellular glycosphingolipid pat-
terns such as those occurring during neuronal development,
oncogenic transformation or acquisition of drug resistance in tu-
mor cells are paralleled by changes in the expression of the corre-
sponding glycosyltransferases [53,54]. However, it is not to be
excluded the possibility that also differential intracellular meta-
bolic ﬂows and different half life for each glycosphingolipid could
inﬂuence the resulting GSL patterns [55]. In other words, the regu-
lation of intracellular sphingolipid trafﬁc might be of equal impor-
tance as the control of biosynthetic enzymes expression in
determining the ﬁnal glycosphingolipid composition of the plasma
membrane. Nevertheless, all together the processes of neobiosyn-
thesis and subsequent transport to the plasma membrane of the ﬁ-
nal compounds seem to require too much time to be used to
modify the plasma membrane GSL concentration and pattern in re-
sponse to extracellular signals. In addition, even if it has been re-
ported that the glycosphingolipid half life is short in neurons, it
is long or very long in the majority of cells. In ﬁbroblasts, the half
life of gangliosides is long [56] and the major loss of cellular sphin-
golipids is by due to their shedding to the extracellular environ-
ment [46], rather than to complete degradation. It has beenLYSOSOMES
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S. Sonnino et al. / FEBS Letters 584 (2010) 1914–1922 1917determined that up to 7–8% of the total cell sphingolipids are shed
every day. Recalling that the recycling of sphingosine is quantita-
tively a very important process, the neobiosynthesis of sphinga-
nine is primarily necessary to replace shed compounds.
The fact that some enzymes of the glycosphingolipid metabo-
lism are associated with the plasma membrane, goes beyond the
traditional view that glycohydrolases are only in the lysosomes
and glycosyltransferases are only in the Golgi. However, even 40
years ago, it was proposed the presence of glycosyltransferases,
working on both glycoproteins and glycolipids, at the cell surface
[48].
The association of glycosphingolipid metabolic enzymes with
the plasma membranes, the information on their activity on natu-
ral substrates in living cells, the availability of couples of enzymes,
like sialidase and sialyltransferase, capable to catalyze opposite
reactions, suggest that changes of glycosphingolipid structures at
the plasma membrane could be the way to change rapidly the
GSL plasma membrane concentration, to modify the glycosphingo-
lipid pattern and to modulate cell functions. In addition to this, the
plasma membrane GSL changes would be only dependent by the
enzyme kinetic properties, that can change in a very fast way
through conformational changes determined by ligand-triggered
interactions.3. Plasma membrane-associated enzymes and
glycosphingolipid composition
Several enzymes of the glycosphingolipid metabolism have
been found associated with the plasma membranes: sialidase and
sialyltransferase, b-hexosaminidase, b-galactosidase and b-
glucosidase.
Gangliosides are glycosphingolipids containing sialic acid resi-
dues. The negatively charged sialic acid is linked as external unit
by a linkage, in mammals. The a linkage of sialic acid is hydrolyzed
by four known sialidases. Neu1 is the lysosomal enzyme, known
from long time as the enzyme responsible for catabolism of sialo-
compounds; Neu2 is cytosolic and Neu4 is mitochondrial but their
in vivo role is basically unknown. Neu3 is associated with the plas-
ma membranes and seems to be involved in functional processes
[57].
Sialic acid is attached to sugars by sialyltransferases. Several
sialyltransferases speciﬁc for different acceptors of sialic acid from
cytosine monophosphate-N-Acetyl neuraminic acid (CMP-Neu5Ac)
have been identiﬁed into the trans-Golgi [58–60].
The ﬁrst information on the association of sialidase and sialyl-
transferase with plasma membranes (in speciﬁc, synaptosomal
membranes) dates back to the Seventies [48,49,61–64]. On this ba-
sis, it has been hypothesized that a sialylation–desialylation cycle
for gangliosides at the plasma membrane level, could exist and
be involved in a putative role played by gangliosides in neurons.
The existence of a plasma membrane-associated sialidase distinct
from the lysosomal enzyme was ﬁrst suggested by enzymatic
and immunological studies [65–68], as well by metabolic studies
[69,70]; a membrane-bound sialidase was puriﬁed from human
brain grey matter [71] and from bovine brain [72,73]. In 1999,
the existence of a speciﬁc membrane-associated sialidase, coded
as Neu3, distinct from other known sialidases, was unambiguously
proven by cloning its cDNA sequence for human [74], bovine [50]
and mouse [75]. Neu3 preferentially hydrolizes the a2–3 external
ketosidic linkages, being ineffective on the inner sialic acid residue.
An increase of Neu3 activity modiﬁes the cell surface ganglioside
composition by converting polysialylated species to GM1, and
GM3 to lactosylceramide, with deep consequences on neuronal dif-
ferentiation [75] and apoptosis in human colon cancer and normal
ﬁbroblasts [76,77]. In mouse and human neuroblastoma cells, theNeu3 expression increases during pharmacologically induced neu-
ronal differentiation [78], and Neu3 gene transfection accompa-
nied by a corresponding increase in the enzyme activity
enhanced the extension or branching of neurites induced by 5-
bromodeoxyuridine [75] or by dibutyryl cAMP treatment, and
was sufﬁcient by itself to induce neurite outgrowth [78]. Con-
versely, inhibition of plasma membrane sialidase activity resulted
in the loss of neuronal differentiation markers [70,79]. In cultured
hippocampal neurons, the activity of Neu3 locally regulated GM1
surface levels, and was essential for axonal growth and regenera-
tion after axotomy [80]. In these cells, Neu3 activity was asymmet-
rically concentrated at the end of one single neurite, and
determined its axonal fate by a local increase in TrkA activity
[81]. On the other hand, reduction of Neu3 expression with the
consequent remodeling of the ganglioside pattern still induces dif-
ferentiation in neuroblastoma cells [82]. This introduces the notion
that the same differentiation process can be induced by two differ-
ent cell surface glycolipid patterns.
Neu3 and gangliosides co-localize in lipid rafts [83]. The non-
random distribution of Neu3 at the cellular surface introduces
the possibility that the biological effects of this enzyme might be
due to the local reorganization of glycosphingolipid-based signal-
ing units. Remarkably, Neu3 modulates the cell surface glycolipid
composition acting by trans interactions, being capable to hydro-
lyze substrates belonging to the surface of neighboring cells [84].
In colon and renal cancer, this sialidase seemed to be responsi-
ble for maintaining high cellular levels of lactosylceramide, that
would exert a Bcl-2-dependent antiapoptotic effect, contributing
to the survival of cancer cells and consequent tumor progression
[76,85].
Neu3, together with plasma membrane-associated b-galactosi-
dase and b-glucosidase, participates to the production of bioactive
ceramide at the cell surface of human ﬁbroblasts in culture [86].
The structure of the plasma membrane-associated b-galactosidase
is still unknown; it could be the lysosomal enzyme transferred to
the plasmamembrane during a cell surface repairing process by fu-
sion of lysosomes with plasma membranes [87]. Two distinct
b-glucosidases are associated with the plasma membranes of ﬁbro-
blasts. One enzyme could derive from lysosomes, but the other is
the known b-glucosylceramidase (GBA2) displaying a structure dif-
ferent from that of lysosomes [88]. The expression levels of the
three plasma membrane-associated enzymes Neu3, b-galactosi-
dase and b-glucosidase are interdependent and affected by those
of other enzymes of glycosphingolipid metabolism. The overex-
pression of Neu3 in human ﬁbroblasts induces an up-regulation
in the expression/activity of b-galactosidase and b-glucosidase,
with the consequent increase of ceramide cell content and cell
apoptosis [86]. The increase of cell surface ceramide is paralleled
by a very scant reduction of ganglioside GM3, the main ganglioside
in ﬁbroblasts and the substrate of Neu3. In fact, the overexpression
of Neu3 leads to an increased expression of GM3 synthase. This is,
probably, the way choose by the cell to contrast the reduction of
GM3 due to the concomitant increase of Neu3, b-galactosidase
and b-glucosidase activities, that catabolize it to ceramide. The in-
creased expression of sialyltransferase 1 (SAT-1) requires a high
amount of lactosylceramide, which is consequently less available
for the biosynthesis of globotrihexosylceramide (Gb3Cer). Fig. 2
shows the TLC glycolipid pattern and a scheme of the relationships
between several enzymes of the glycosphingolipid metabolism.
As for Neu3, plasma membrane b-galactosidase and b-glucosi-
dase display trans activity in living cells being capable to act on
substrates belonging to neighboring membranes with no addition
of activator proteins or detergents [52].
The presence of b-hexosaminidase A protein in the external
leaﬂet of plasma membrane has been also demonstrated in cul-
tured ﬁbroblasts [51]. The membrane protein shows in vitro enzy-
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Fig. 2. TLC sphingolipid pattern of human ﬁbroblasts overexpressing plasma membrane-associated sialidase Neu3, and scheme of the metabolic processes determining the
pattern. (Panel A) Sphingolipids from normal (1) and Neu3 overexpressing (2) human ﬁbroblasts were labeled by cells administration with 3.6  108 M [3-3H]sphingosine
for 2 h pulse followed by 48 h chase. Lipids were then extracted and analyzed by HPTLC with the solvent system 55:45:10 CHCl3/CH3OH/0.2% aqueous CaCl2 and visualized by
digital autoradiography. (Panel B) Scheme of the metabolic pathways and of the enzymes involved in determining the sphingolipid pattern. The violet arrows indicate the
enzyme activities up-regulated in Neu3 overexpressing cells.
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in the presence of GM2 activator protein. Data on plasma
membrane-associated b-hexosaminidase A activity on endogenous
compounds located at the cell surface have not been demonstrated
yet. Immunological and biochemical characterization of the mem-
brane-associated b-hexosaminidase indicated that this enzyme has
the same structure of the lysosomal enzyme. This suggests that a
regulated fusion of lysosomes with the plasma membrane might
represent a general mechanism of repair for the plasma membrane
[87], but could be the way for all the lysosomal glycolipid-metab-
olizing enzymes to reach the cell surface where they play an active
role in remodeling its glycolipid composition together with speciﬁc
and different membrane-associated enzymes.
Some information is also available about the in situ sialylation
of gangliosides at the cell surface. The original report on the exis-
tence of a synaptosomal membrane sialyltransferase in calf brain
[49] has been conﬁrmed by metabolic studies in chicken embryos
[89,90] and rat brain [91,92]. More recently it has been shown that
dexamethasone treatment markedly increased GM3 synthesis, due
to enhanced gene expression and increased enzyme activity of
GM3 synthase. Radiolabeling metabolic studies indicated that this
event was localized at the plasma membrane [93], thus conﬁrming
that glycolipid sialylation might occur outside the Golgi compart-
ment, contributing to the local modulation of cell surface glyco-
lipid patterns. Respect to this concern several points need to be
clariﬁed, particularly about the availability at the cell surface of
the CMP-sialic acid. It cannot be excluded a role played by the
CMP-sialic acid transporter, a speciﬁc transmembrane carrier lo-
cated into the Golgi membrane, able to translocate the activated
sialic acid present in the cytosol inside the Golgi compartment
where it becomes co-substrate of the sialyltransferases [94,95].
We cannot exclude that this transporter could be translocated to
the cell surface by fusion of vesicles coming from the trans-Golgi
network (TGN) with the plasma membrane and here, being ex-
posed with the same orientation than in the Golgi membrane, it
could translocate the cytosolic CMP-sialic acid outside the cell for
the sialylation of glycolipids or glycoproteins by enzymes located
at the cell surface. On the other hand sialidases with trans-sialidase
activity has been shown to operate on glycoconjugates, and wecannot exclude that PM-sialyltransferases transfer sialic acid di-
rectly from a sialoconjugate to another [96].
In addition to processes mediated by glycohydrolases and gly-
cosyltransferases we like to recall shortly two further possibilities
to modify the membrane glycolipid pattern.
Ganglioside lactones [97] are obtained in the presence of cata-
lytic proton concentrations [98], and it has been shown that the
lactonization process inﬂuenced the conformational, aggregational
[99] and biological properties of gangliosides like GD1b [100].
GD1b is able to directly interact with several cellular proteins
[14], and to modulate several plasma membrane-associated pro-
tein kinase activities [100]. But when gangliosides were lactonized,
these properties were strongly reduced or lost [100]. This suggests
that lactonization/delactonization might represent a localized
event able to trigger speciﬁc ganglioside-mediated cellular events.
In vivo GD1b lactonization occurs in neurons through a process
that suggests the presence of a speciﬁc enzyme associated to the
plasma membrane [101].
Metabolic remodeling is not the only local event that could con-
tribute to the surface composition and organization of cell glyco-
sphingolipids. It is known that glycosphingolipids and
sphingolipids can be released from the cell surface to the extracel-
lular milieu in the form of monomers or aggregates, including
shedding vesicles [46,47,102] at least in cultured cells, whereas
no data are available on mammalian tissues. Glycolipid-containing
shedding vesicles seemed to originate from caveolin- and glyco-
lipid-enriched membrane areas, thus their release could be used
by the cell to modify the lipid membrane domain composition
and organization. On the other hand, it has been suggested that
shed gangliosides could be taken up by neighboring cells, modify-
ing their lipid composition [103]. However, the metabolic fate of
shed glycolipids after reuptake seems oriented toward degrada-
tion, thus the contribution of this event to the determination of cell
lipid composition remains unclear [47].
4. Glycosphingolipids and membrane curvature
Glycosphingolipids are components of the external leaﬂet of the
plasma membranes [43,104] where they can segregate forming
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ing and this introduced the concept that glycolipid–protein inter-
actions are instrumental to modulate cell signaling processes and
cell functions. This might occur through speciﬁc interactions but
can also be associated with the physico-chemical properties of
the membrane determined by the lipid pattern, lipid amphiphilic
and geometrical properties and lipid organization. Glycolipids,
and particularly gangliosides, with their complex and bulky oligo-
saccharide structures, need a very large interfacial area into the
membrane, much larger than that required by the glycerolipids.
Phase separation with clustering of glycosphingolipids in a
phospholipid bilayer is a spontaneous process driven by the mini-
mization of the interfacial free energy [2]. The segregation of
amphiphilic molecules with a bulky hydrophilic headgroup implies
the acquisition of a positive membrane curvature [105]. The inter-
facial area increases with the size of the oligosaccharide chain,
with a corresponding more positive membrane curvature and
more pronounced segregation. Glycosphingolipid hydrophobic
moieties are quite homogenous, so the different geometrical prop-
erties of the monomers inserted into the membrane are mainly
connected to the structural features of the oligosaccharide portion
[106]. Any variation, even small, in the head group hindrance pro-
duces ampliﬁed effects on the membrane surface, particularly in li-
pid rafts, where glycolipids are strongly enriched. Consistent
modiﬁcations to the aggregate curvature should occur when a
polysialoganglioside like GT1b with a surface area of 100.8 Å2,
highly enriched at the nerve endings, is rapidly hydrolyzed by
the plasma membrane-associated Neu3 to ganglioside GM1, that
displays a value of 95.4 Å2. The ﬁnal effect exerted by this 5% of dif-
ference, is incredibly ampliﬁed in a membrane. Micelles of GM1 in
solution contain about 320 monomers and are much less curved
and more asymmetric with respect to micelles of GT1b that con-
tain only about 180 monomers. Translation of this to a natural
plasma membrane is difﬁcult, but we could expect a general reor-gradual reduction of 
membrane curvature 
inversion of membrane 
curvature
GLYCOHYDROLASES
and 
SPHINGOMYELINASE
membrane enriched in 
gangliosides and 
sphingomyelin
m
A
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Fig. 3. Changes of membrane geometry and organization due to the activities of plasma
The sphingolipid pattern of plasma membrane can be locally modiﬁed by glycohydrola
action of these enzymes on the sphingolipids present on the external leaﬂet of the plasm
enrichment in ceramide of the plasma membrane can cause the passage from a positiveganization of all the components, necessary to accept the new
physico-chemical parameters. More dramatic should be the effect
deriving from the sequential hydrolysis of GM3 to ceramide by
the coordinated action of plasma membrane-associated Neu3, b-
galactosidase and b-glucosidase. GM3 is characterized by the a-
Neu5Ac-(2–3)-b-Gal-(1–4)-b-Glc-chain and is the major mammal
ganglioside being widely distributed in all cells. It displays a pack-
ing parameter near 0.5, optimal to allow the molecule to stay in a
cell membrane with very mild curvature. In contrast to this, cera-
mide is a very hydrophobic compound and basically water-insolu-
ble. In a membrane it can be considered amphiphilic because the
two hydrocarbon chains interact with the layer lipid core, while
the primary hydroxyl group and the amide planar linkage are lo-
cated at the water–lipid interface. It is claimed that, when large
amounts of ceramide are produced from complex sphingolipids,
they rapidly segregate forming macrodomains instrumental for
the cell signaling [107]. The removal of the head group from the
complex sphingolipid produces ceramide. The experimental deter-
mination of ceramide packing parameter is not simple due to the
high insolubility of the molecule in aqueous solutions and to the
complexity of mixed systems. Nevertheless, we can expect an in-
crease of packing parameter moving from sphingomyelin to cera-
mide due to the drastic reduction of head group. A higher
packing parameter is suitable for a negative curvature (see Fig. 3)
and seems to promote endocytosis and vesicle formation [108].
This process requires total rearrangement of the membrane, ob-
tained by excluding some components and sorting others. In this
context is not difﬁcult to imagine that the original lipid–protein
interactions or the forces exerted by the lipid environment on
the protein conformation are concomitant with changes of the pro-
tein biological properties. The main example of this is the conver-
sion of GM3 to ceramide in human ﬁbroblasts. When ceramide
levels are increased in these cells due to the ectopic expression
of Neu3, and the consequently increased activities of b-galactosi-endovesciculation
ceramide
sphingomyelin
glycosylceramides
 
S
embrane enriched in 
ceramide
membrane-associated enzymes involved in the sphingolipid metabolism. (Panel A)
ses and sphingomyelinases associated to the cell surface. (Panel B) The combined
a membrane can induce a gradual change in membrane curvature. Moreover, the
to a negative curvature which could favour the formation of endovesicles.
1920 S. Sonnino et al. / FEBS Letters 584 (2010) 1914–1922dase and b-glucosidase, cells strongly reduced their proliferation
and rapidly enter apoptosis [86].
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